For example, the Breast Cancer Linkage Consortium (BCLC) did not find an increase in the incidence of haematologic malignancies through BRCA1 or BRCA2 mutation except that of lymphoma by BRCA1 mutation [3,4]. The gene discussed is BRCA2; the disease is breast carcinoma.